Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Physiomics ( (GB:PYC) ) has shared an update.
Physiomics plc has updated its website with a recent presentation and Q&A session from its Interim Results meeting, accessible via their website. This update aims to provide stakeholders with insights into the company’s current operations and strategic direction, potentially impacting its market positioning and stakeholder engagement.
More about Physiomics
Physiomics plc is a leading company in mathematical modelling, data science, and biostatistics, focusing on the development of new therapeutics and personalized medicine solutions. The company aids biotech and pharma firms in optimizing drug development by leveraging expertise in Modelling & Simulation, Biostatistics, Data Science, and Bioinformatics. Their proprietary Virtual Tumour technology has been instrumental in over 100 commercial projects, working with clients such as Merck KGaA, Astellas, and Bicycle Therapeutics.
YTD Price Performance: -44.67%
Average Trading Volume: 4,954,080
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.26M
Find detailed analytics on PYC stock on TipRanks’ Stock Analysis page.